An update on overall survival from a multi-center, open-label, pivotal phase 2b study of AZEDRA (R) (iobenguane I 131) in patients with iobenguane scan positive locally advanced or metastatic pheochromocytoma/paraganglioma (PPGL)-MedSci.cn

An update on overall survival from a multi-center, open-label, pivotal phase 2b study of AZEDRA (R) (iobenguane I 131) in patients with iobenguane scan positive locally advanced or metastatic pheochromocytoma/paraganglioma (PPGL)

Pryma, D; Chin, B; Noto, R; Dillon, J; Solnes, L; Jensen, J; Lin, T; White, T; Stambler, N; DiPippo, V; Mahmood, S; Wong, V; Jimenez, C

JOURNAL OF NUCLEAR MEDICINE, 2019; 60 ():

科室
- - 订阅+
  - 更多科室
工具
服务